Relationship between clinical effects, serum drug concentration, and concurrent drug interactions in depressed patients treated with citalopram, fluoxetine, clomipramine, paroxetine or venlafaxine
C. Charlier et al., Relationship between clinical effects, serum drug concentration, and concurrent drug interactions in depressed patients treated with citalopram, fluoxetine, clomipramine, paroxetine or venlafaxine, HUM PSYCHOP, 15(6), 2000, pp. 453-459
Citations number
20
Categorie Soggetti
Neurosciences & Behavoir
Journal title
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
The relationship between clinical effects and plasma concentrations of cita
lopram, fluoxetine, clomipramine, paroxetine and venlafaxine was studied in
119 cases of major depression. Clinical effects were evaluated using the C
linical Global impression (CGI) improvement scale. Antidepressants were qua
ntified by a separative chromatographic methodology. Plasma concentrations
in responder patients were compared with the plasma concentrations proposed
in literature as effective values. We found that the usual therapeutic win
dow is convenient for citalopram and clomipramine, but could be reduced for
fluoxetine and increased for venlafaxine and paroxetine. Concurrent drug i
nteractions were also evaluated and clomipramine or citalopram plasma level
s were found to be influenced by the presence of associated drugs. A larger
study is needed, taking into account not only plasma concentrations and cl
inical effects, but also some pharmacokinetic data, especially the metaboli
c activity characterising the patient, and the presence or not of associate
d drugs. Copyright (C) 2000 John Wiley & Sons, Ltd.